It is noted that there were no significant differences in CSF VILIP-1 levels among Alzheimer’s disease patients, mild cognitive-impaired individuals, and cognitively normal individuals who displayed amyloid-β positivity [190]. The gene discussed is VSNL1; the disease is early-onset autosomal dominant Alzheimer disease.